Press Release

April 15, 2025

DSM B.V. publishes 2024 Annual Report

print

Kaiseraugst (Switzerland), Maastricht (Netherlands), April 15, 2025

DSM B.V. (‘DSM’) today announces the publication of its 2024 Annual Report.

DSM, a 100%-owned subsidiary of dsm-firmenich AG, a leader in nutrition, health and beauty, continues to publish an annual report to meet financial and regulatory obligations.

KPMG performed an audit of the financial statements.

The full version of the 2024 Annual Report is available on dsm-firmenich.com.

 

For more information, please contact:

dsm-firmenich investor relations enquiries:
Email: investors@dsm-firmenich.com

dsm-firmenich media enquiries:
Email: media@dsm-firmenich.com

 

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com

 

Disclaimer 

This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. The information provided in this press release is provided as of the date of its issue. Furthermore, the information provided in this press release qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. dsm-firmenich does not assume any obligation to update any information or forward-looking statement provided in this press release unless required by law. The English language version of this press release prevails over other language versions.